Table: Amyloid-Directed Antibodies for Alzheimer's Disease (online only)

The Medical Letter on Drugs and Therapeutics

ONLINE
ONLY
ARTICLE

August 5, 2024

View Complete Issue Table of Contents 2019

Download PDF: US English

Show Related Terms Hide Related Terms

View Complete Issue

Send Article Feedback

Med Lett Drugs Ther. 2024 Aug 5;66(1708):e1-2 doi:10.58347/tml.2024.1708e

Disclosures

Objective(s)

Select a term to see related articles Alzheimer's disease donanemab Kisunla lecanemab Leqembi

Updated 9/17/2025

View the Table: Amyloid-Directed Antibodies for Alzheimer's Disease

Download PDF: US English

The Medical Letter, Inc. does not warrant that all the material in this publication is accurate and complete in every respect. The Medical Letter, Inc. and its editors shall not be held responsible for any damage resulting from any error, inaccuracy, or omission.

This article has been freely provided.